China Biologic Products, Inc. (NASDAQ:CBPO), a leading fully integrated plasma-based biopharmaceutical company in China , today announced its financial results for the fourth quarter and fiscal year 2013. China Biologic Products Inc (NASDAQ:CBPO) stock performance was -6.25% in last session and finished the day at $32.85. Traded volume was 32,311.00million shares in the last session and the average volume of the stock remained 21.68K shares. … Continue reading Biotech Losers: China Biologic Products (NASDAQ:CBPO), Heat Biologics (NASDAQ:HTBX), Recro Pharma Inc (NASDAQ:REPH), Egalet Corp (NASDAQ:EGLT)